Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994  and it became an official association (under Dutch law) in 2004.
Pharmaceutical Care is the pharmacist's contribution to the care of individuals, in order to optimize medicines use and improve health outcomes.

Conferences Working groups

1st PCNE Working Conference 1999, Hillerød, Denmark

The outcomes of Pharmaceutical Care

26-29 January 1999

In January 1999, the Pharmaceutical Care Network Europe (PCNE) together with the Danish College of Pharmacy Practice, Pharmakon, in Hillerød, organised a working conference (the first!) during which the outcomes of pharmaceutical care were the core topic. Participating were a mixture of researchers in the field of outcome assessment and practising pharmacists from 18 different countries, including some from outside Europe.

A document with all the abstracts and reports can be downloaded here.


Organising committee: Foppe van Mil (Chairman, the Netherlands), Bente Frøkjær (Secretary, Denmark), Cecilia Claeson (Sweden), Marion Schaefer (Germany), Birthe Søndergaard (Denmark), Mary Tully (United Kingdom)

During the working conference, 5 lectures were given. Reports of the lectures can be found in the Proceedings WC 1999.


- Measuring outcomes in pharmaceutical care (Mary Tully, United Kingdom)

- Constructing instruments: the example of Health Related Quality of Life (Per Bech, Denmark)

- Assessing and translating instruments (Pedro Lopez Ferreira, Portugal)

- Measuring compliance, how it can be done (John Urquhart, the Netherlands)

- Applying outcome measurements in research practice (James McElnay, United Kingdom)

During this conference, seven workshops were held:

(Workshop reports can be found in the Proceedings WC 1999)

Workshop 1+2: Assessing patient satisfaction and health status (Hanne Herborg, Denmark & Linda McKeigan, Canada)

Workshop 3: Assessing knowledge and attitude towards medicine (Frank Verheyen & Marion Schaefer, Germany)

Workshop 4: Assessing behaviour and coping strategies (John Urquhart, the Netherlands, Ian Sturgess & James McElnay, United Kingdom)

Workshop 5: Assessing use of medical resources and the economic impact (Hakan Brodin, Sweden & Francisco Batel Marques, Portugal)

Workshop 6: Assessing drug-related problems from the patient perspective (Almut Müller-Jaeger, Germany & Foppe van Mil, the Netherlands)

Workshop 7: Assessing appropriateness of drug therapy and changes in drug therapy (Judy Cantrill and Mary Tully, United Kingdom)